CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-15 | Soffer Gad Chief Operating Officer | Exercise or conversion | +80,128 | 114,639 | ||
| 2015-05-15 | Soffer Gad Chief Operating Officer | Shares withheld for taxes | −48,851 | $37.30 | $1.8M | 65,788 |
| 2015-05-15 | Soffer Gad Chief Operating Officer | Grant or award · Restricted Stock Units | +80,128 | 73,718 | ||
| 2015-05-15 | Soffer Gad Chief Operating Officer | Grant or award · Restricted Stock Units | +22,111 | 44,221 | ||
| 2015-05-15 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion | +31,250 | 43,650 | ||
| 2015-05-15 | Clark Mitchall G. Chief R & QA Officer | Shares withheld for taxes | −13,066 | $37.30 | $487K | 30,584 |
| 2015-05-15 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Restricted Stock Units | +31,250 | 84,134 | ||
| 2015-05-14 | SEIDENBERG BETH C Director | Other disposition | −194,200 | 2,404,828 | ||
| 2015-05-14 | SEIDENBERG BETH C Director | Other disposition | −71,822 | 71,822 | ||
| 2015-05-14 | Kleiner Perkins Caufield & Byers XV, LLC 10% owner | Other disposition | −194,200 | 2,404,828 | ||
| 2015-05-14 | Kleiner Perkins Caufield & Byers XV, LLC 10% owner | Other disposition | −5,800 | 71,822 | ||
| 2015-04-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,600 | $62.70 | $163K | 392,300 |
| 2015-04-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,600 | $60.01 | $156K | 394,900 |
| 2015-03-26 | DOBMEIER ERIC Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2015-03-10 | MARCUS JOEL S Director | Purchase | +1,500 | $29.99 | $45K | 4,000 |
| 2015-03-09 | MARCUS JOEL S Director | Purchase | +2,500 | $29.32 | $73K | 2,500 |
| 2015-02-18 | Gallagher Carol Giltner Director | Purchase | +11,000 | $18.00 | $198K | 62,656 |
| 2015-01-16 | MARCUS JOEL S Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2015-01-16 | Clark Mitchall G. Chief R & QA Officer | Grant or award | +12,400 | 12,400 | ||
| 2015-01-16 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | +41,333 | 41,333 |
Page 67 of 71 · 1,403 trades